Add like
Add dislike
Add to saved papers

Doping of nematic cyanobiphenyl liquid crystals with mesogen-hybridized magnetic nanoparticles.

Magnetic nanoparticles (MNPs) functionalized with (pro-)mesogenic ligands are implemented into a nematic liquid crystal (LC) and studied regarding both colloidal stability and magneto-optical behavior. In this study, the particle surface is specifically engineered to tune the MNP interactions with the LC host. For this purpose, four types of (pro-)mesogenic ligands (ML) are synthesized, which are composed of three structural parts, i.e., a rigid, LC motif (i.e., cyanobiphenyl) and a functional group for nanoparticle binding, both linked via a flexible spacer of different alkyl chain lengths. Electrostatically stabilized CoFe2 O4 and γ-Fe2 O3 nanoparticles with narrow size distribution and sizes below 3 nm are obtained via co-precipitation and subsequently functionalized to yield MNP@ML nanoparticles. Studies on the behaviour of the MNP@ML nanoparticles in the commercial LC host (i.e., 4-pentyl-4'-cyanobiphenyl (5CB)) in the bulk and in thin films in LC test cells, reveal the initial formation of some heterogeneities after transition from the isotropic to the nematic phase. Homogenous MNP@ML-5CB hybrids with long-term, colloidal stability, however, are obtained after magnetic separation of initially formed particle aggregates. In particular, MLs with carboxy groups and high structural flexibility (i.e., long linker lengths) are shown to be well suited to form stable MNP colloids, allowing for high MNP doping levels. As compared to undoped 5CB, the CoFe2 O4 @MLx-5CB hybrids show an increased sensitivity to the magnetic field, affecting the Fréedericksz transition. The strongest effect, however, is observed in magnetic and electric fields. The coupling of the ultrasmall, spherical MNPs with the LC director in the magnetic field suggests the formation of LC-induced, anisometric MNP clusters.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app